Thermo Fisher Scientific is reiterated as a 'buy' with a fair value estimate of $619 per share, reflecting confidence in its recovery and strategic positioning. TMO's acquisition of Clario Holdings ...
University leaders announced that recovery operations have yielded remarkably successful results two months after a lightning ...